Free James Kimball
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Free James Kimball |
How Liquid Deprenyl Citrate (LDC) Worked
And The Human Trial Results From Doctors
And Patients Using LDC For 9 Years
Prior and while Discovery Experimental and Development, Inc. (DEDI) was developing LDC; DEDI and its associates were reviewing the hundreds of trial results in Europe using the chemical Selegiline Hydrochloride or similar.
Not all the trials in Europe reflected their alleged Selegiline HCL products, or similar were always effective or consistent. The trial results revealed enough information to suggest that if a Selegiline HCL product, or similar were developed to perfection, the results might be astounding.
The trial results of the products produced in Europe revealed those products to be sporadically effective in: Parkinson's Disease, Alzheimer's Disease, tremors, dementia, senility, cognitive functions, mobility and pain relief in people. While one late trial result revealed a dramatic increase in life extension in rats.
It was concluded that if a properly made Selegiline HCL product, or similar were to be developed, it would not produce sporadic results and could very well produce better results while addressing more afflictions than had already been revealed in European trials.
The way a properly made Deprenyl product should work was revealed by the Europeans. A properly made Deprenyl product should pass through the blood brainbarrier easily and come to rest on a tissue in the brain called the Substantia Nigra.
Very few products will pass through the blood brain barrier. This barrier is the body's natural defense mechanism to stop foreign objects from getting into the brain, damaging brain cells and killing us.
However, for a Deprenyl product to work it needed to pass easily through the body's natural barrier, so it could reach the brain and stimulate the Substantia Nigra tissue.
The Substantia Nigra is a tissue in the brain which produces a chemical within the brain. The scientists have named the chemical produced by this Substantia Nigra tissue, dopamine.
This chemical called dopamine is one of our body's majorlife links. Without the Substantia Nigra tissue producing dopamine, it is concluded we would not live past the age of 5 years old. However, it is a hypothesized that if a product were developed that could cause the Substantia Nigra to continue to produce dopamine, the life expectancy in humans could be increased 50% or higher.
This is exactly what happened with the rats that received a properly made Deprenyl product.
The shortest living rat, receiving a properly made Deprenyl product, lived about 10% longer than the longest living rat that did not receive the product. However, the longest living rats receiving the properly made Deprenyl lived almost 80% longer than the longest living rat that did not receive the Deprenyl product at all.
The rat study absolutely proved that a properly made Deprenyl product had the potential not only to address a multitude of serious life-threatening and debilitating diseases, it had the distinct possibility of increasing the life of humans by 50% or more.
The Substantia Nigra tissue degenerates as we get older and produces less and less dopamine. The chemical dopamine keeps the brain cells protected from attackers which destroybrain cells. Scientists have named some of these attackers Monoamine Oxidize. Dopamine is a Monoamine Oxidize inhibitor, and stops the Monoamine Oxidizers from attacking, immobilizing, and killing brain cells.
As we age, and the Substantia Nigra degenerates, this tissue produces less dopamine to protect brain cells. The Monoamine Oxidize then starts its lethal attack against brain cells. As the brain cells are being attacked, people become immobile, suffer from dementia, and senility, memory and speech problems occur and so on.
If for some reason the Substantia Nigra degenerates too quickly or something goes wrong with that tissue, the dopamine content drops off faster than normal and these people suffer from terminal disease called "Parkinson's Disease".
One of the actions of a properly developed and manufactured Deprenyl product is, once it gets into the brain, it stimulates the Substantia Nigra tissue to produce more dopamine. With the dopamine content coming back to normal, the Parkinson's symptoms appeared to improve in the European trials.
When DEDI first developed their LDC; their liquid Selegiline, the purity level, was at 99% pure. The purity level was increased shortly thereafter to 99.9903% using a sophisticated purifying procedure developed by Dr. Barltrop. Dr. Owen had decided upon another product; citric acid to use as one of the stabilizing agents in LDC. Citric acid is another one of the few chemicals which will pass through the blood brain barrier easily.
In essence what Dr. Owen and Dr. Barltrop had developed was a brand new product, which was all natural, with 2 of its ingredients passing through the blood brain barrier easily, to accomplish their task.
Once DEDI was aware that citric acid passes easily through the blood brain barrier; DEDI did what the FDA should have done over 50 years ago.
DEDI Does What The FDA Should Have Done
Kimball contacted one of the foreign research teams DEDI was working with, at the University of Toronto. Because orange juice contains citric acid, DEDI wanted to know two things. If a person were to take any medication with 4 - 8 oz glass of orange juice, would the medication the person was taking, get into the brain? And if so, how long should a person wait after drinking a 4 0 8 oz glass of orange juice, before taking medication, or dietary supplement, so those products will not get into the brain.
The research team got back with Kimball and advised him, that most any medication or dietary supplement taken with orange juice, would in fact get into the brain, using citric acid as its carrier. They advised Kimball if a person took medication or dietary supplements 1/2 half an hour prior, or 1/2 hour after drinking orange juice, the substance in general should not get through the blood brain barrier.
As soon as that information was received, DEDI sent out a notice to all its customers advising them not to take any medication, or dietary supplements within 30 minutes of drinking orange juice due to the fact those substances could penetrate the blood brain barrier and cause adverse side effects. DEDI advised them to check with their physician before taking any medication, or supplement with orange juice.
Additionally DEDI put on the labels of its products DO NOT take this product or any other product within 30 minutes of drinking orange juice or ingesting any substance containing citric acid. DEDI received hundreds of calls from doctors asking why. When they were explained why, the doctors agreed.
The trial results of LDC. In late 1991 DEDI's new LDC was released through doctors and to the public through Mexico.
The reports started coming in almost immediately, (within 90 days) and they were beyond belief. DEDI chose not to believe many of the reports and had a wait and see attitude.
By mid-1992 the repetitive reports coming in from doctors and individuals that had been using LDC for 8 months were overwhelming and now believable.
Doctors and individuals repetitively reported that LDC was very effective with the following medical afflictions:
As The Years Went On, Other Benefits Showed Up
Adverse Side Effects Noted In 9 Years
Medical doctors, homeopathic doctors and naturopathic doctors reported no adverse side effects in nine years of use. Eldepryl, the FDA's approved version of Selegiline HCL reported deaths in patients using the drug Dilantin with Eldepryl. However, medical doctors reporting to DEDI stated, they were prescribingDilantin for their patients using LDC, without any adverse side effects whatsoever.
DEDI received from individuals, reports of adverse side effects which included, headaches in 3% of LDC users, backache in 1% of LDC users, which lasted 12-36 hours. All doctors attributed these adverse effects to be a placebo effect and not noteworthy. However DEDI kept those records anyway.
Examples of Repetitive Reports
Parkinson's Disease. Many doctors and individuals afflicted with terminal Parkinson's disease reported dramatic improvement in their condition. One Parkinson patient in Hollywood, California, Mrs. Freeman found out about LDC in Mexico in late 1991. Mrs. Freeman was in the final stages of Parkinson's. She was bedridden and needed assistance in turning over in bed. Ms. Freeman at the time, in 1991 had Parkinson Disease for about10years and had declined to being bedridden. She was in her mid 50's at the time.
Ms. Freeman, at her medical specialist's recommendation had tried every medication available for Parkinson's disease, including Eldepryl. Eldepryl, Mrs. Freeman told DEDI; did absolutely nothing to help her.
Ms. Freeman, came across LDC in late 1991 and decided to try it. Within weeks she was out of bed, and within months she was back to almost normal, only having a few tremors. In 1992 Mrs. Freeman flew from California to Wesley Chapel, Florida to thank Kimball for developing LDC and saving her life. Mrs. Freeman also flew from California to Florida to testify for Kimball at Kimball's rigged trial in 2000. Rreview Kimball's Rigged Trial
Although not all people afflicted with Parkinson's had a great success story as Mrs. Freeman. The trial results over 9 years of people using LDC for Parkinson's Disease had revealed that 25% of people using LDC for terminal Parkinson's received no benefit at all. 50% of people afflicted with Parkinson's stopped degenerating and the disease stopped its progression. The remaining 25% of the people using LDC for Parkinson's had a dramatic recovery very similar to Ms. Freeman.
Doctors, researchers, and scientists came to the conclusion after reviewing the trial reports over the years; that LDC could not work if the Substantia Nigra tissue had degenerated to such an extent that it could not produce any dopamine even when properly stimulated by LDC. That would amount for LDC not working in 25% of the people.
With the 50% not degenerating any further using LDC, it was concluded that the tissue had only degenerated partially, or had been partially damaged somehow, and the LDC stimulated the remaining active tissue to emit enough dopamine to stave off the progression of Parkinson's Disease.
DEDI's research group concluded, that it was obvious in the 25% group that nearly fully recovered from Parkinson's that the Substantia Nigra tissue had not degenerated totally and was just emitting too little dopamine. When that Parkinson's sufferer took LDC it stimulated the tissue to produce enough dopamine to nearly normalize the person suffering and dying from the disease.
Everyone in the research group concluded, that if people were to take LDC when they first were diagnosed with Parkinson's Disease, the disease might not progress at all, while some people afflicted may return to normal quickly.
Kimball, DEDI's President, and all members of the research group knew it would be impossible to advise the public of these facts when the entire FDA and pharmaceutical industry was bent on getting rid of Kimball and DEDI. DEDI had to operate out of Mexico as quietly as possible to avoid the corruptgiants, the FDA and pharmaceutical cartel.
Dramatic Improvement In Quality of Life
Reported By Thousands
People that had decided to use LDC over 40 years of age for quality of life improvement and the possibility of life extension, reported remarkable results.
People between the ages of 40 and 65 were consistently reporting the following benefits of LDC: dramatic increase in energy, needed less sleep while sleeping much more soundly, became more active, sex drive increased dramatically, were much more attentive, and far less irritable, while in general they felt much better than they had in a long time.
People between the ages of 65 and 85 had basically the same effects as the people 40 - 65 years of age, however, much more spectacular. People were getting out of wheelchairs. People who had given up their driver licenses were driving again. People suffering from dementia, tremors, and speech problems, were acting normal again. Kimball received hundreds of calls from sons and daughters, essentially saying their mothers and fathers got their life back again.
University of Toronto's Late Trial Results
On LDC, Late 1990's
A research team at the University of Toronto (UOT) had been working with Kimball and DEDI since late 1992.
They had discovered the contaminants in the FDA approved drug Eldepryl which was believed to have killed Parkinson's patients. More about Eldepryl and the hidden contaminants is located on the first page of this link under How "Eldepryl" approved by the FDA appeared to kill people.
The UOT research team had been comparing DEDI's LDC product with other similar type products for years. They had tested most all similar products to see if they had the same effects upon patients. They found they did not.
The research team had found that LDC, if administered at 10 MGs, within 24 hours of a person suffering a stroke, with stroke induced paralysis, that the paralysis disappears in 90% of the patients within 30 days using LDC at 10MG daily.
The research team even went one step further in their trial. They did exactly the same trial again with stroke victims, suffering from stroke-induced paralysis; only this time they didn't administer DEDI's LDC until 48 hours after the stroke. This trial revealed that in 50% of the patients; the paralysis disappeared within 60 days using LDC at 10 MGs orally daily.
Freedom Of Choice In Medicine - "Participate In CLC"
GET INVOLVED
Website Support: This website is financially supported by: Global Health Information and Medical Research Institute, GHI/MRI, a non-profit organization. Information about GHI/MRI located at the top of this page.
Also Supported by:
Citizens Liberty Coalition (CLC)
a subsidiary of GHI/MRI
Get Involved
You Can Stop This
"We" Can Show You "How"!!
You can change things "FAST"
!! We'll show you how!!